Literature DB >> 15655809

Current research of hepatic cirrhosis in China.

Xi-Xian Yao1, Shu-Lin Jiang, Dong-Mei Yao.   

Abstract

Hepatic cirrhosis is a common disease that poses a serious threat to public health, and is characterized by chronic, progressive and diffuse hepatic lesions preceded by hepatic fibrosis regardless of the exact etiologies. In recent years, considerable achievements have been made in China in research of the etiopathogenesis, diagnosis and especially the treatment of hepatic fibrosis, resulting in much improved prognosis of hepatic fibrosis and cirrhosis. In this paper, the authors review the current status of research in hepatic fibrosis, cirrhosis and their major complications.

Entities:  

Mesh:

Year:  2005        PMID: 15655809      PMCID: PMC4250726          DOI: 10.3748/wjg.v11.i5.617

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  51 in total

1.  Intracellular pathways mediating Na+/H+ exchange activation by platelet-derived growth factor in rat hepatic stellate cells.

Authors:  A Di Sario; E Bendia; G Svegliati Baroni; F Ridolfi; L Bolognini; G Feliciangeli; A M Jezequel; F Orlandi; A Benedetti
Journal:  Gastroenterology       Date:  1999-05       Impact factor: 22.682

2.  Transformation-dependent calcium influx by voltage-operated calcium channels in stellate cells of rat liver.

Authors:  S Roth-Eichhorn; A Eberheim; H P Bode; A M Gressner
Journal:  J Hepatol       Date:  1999-04       Impact factor: 25.083

3.  OK-432 treatment increases matrix metalloproteinase-9 production and improves dimethylnitrosamine-induced liver cirrhosis in rats.

Authors:  T Ueno; K Sujaku; S Tamaki; R Ogata; M Kin; T Nakamura; M Sakamoto; T Torimura; K Mitsuyama; S Sakisaka; M Sata; K Tanikawa
Journal:  Int J Mol Med       Date:  1999-05       Impact factor: 4.101

4.  Vascular endothelial growth factor production in peritoneal macrophages of cirrhotic patients: regulation by cytokines and bacterial lipopolysaccharide.

Authors:  M Pérez-Ruiz; J Ros; M Morales-Ruiz; M Navasa; J Colmenero; L Ruiz-del-Arbol; P Cejudo; J Clária; F Rivera; V Arroyo; J Rodés; W Jiménez
Journal:  Hepatology       Date:  1999-04       Impact factor: 17.425

5.  Prolyl 4-hydroxylase inhibitor (HOE 077) prevents TIMP-1 gene expression in rat liver fibrosis.

Authors:  I Sakaida; K Uchida; K Hironaka; K Okita
Journal:  J Gastroenterol       Date:  1999-06       Impact factor: 7.527

6.  Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat.

Authors:  Z Qi; N Atsuchi; A Ooshima; A Takeshita; H Ueno
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

7.  Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis.

Authors:  B Bernard; J D Grangé; E N Khac; X Amiot; P Opolon; T Poynard
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

8.  Clinical usefulness of serum matrix metalloproteinase-2 concentration in patients with chronic viral liver disease.

Authors:  Y Murawaki; S Yamada; Y Ikuta; H Kawasaki
Journal:  J Hepatol       Date:  1999-06       Impact factor: 25.083

9.  Bacterial infection in the pathogenesis of variceal bleeding.

Authors:  J Goulis; D Patch; A K Burroughs
Journal:  Lancet       Date:  1999-01-09       Impact factor: 79.321

10.  Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways.

Authors:  G Svegliati-Baroni; F Ridolfi; A Di Sario; A Casini; L Marucci; G Gaggiotti; P Orlandoni; G Macarri; L Perego; A Benedetti; F Folli
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

View more
  3 in total

1.  Pre-existing cirrhosis is associated with increased mortality of traumatic patients: analysis of cases from a trauma center in east China.

Authors:  Zuo-Bing Chen; Lin-Mei Ni; Yuan Gao; Chen-Yan Ding; Yun Zhang; Xue-Hong Zhao; Yun-Qing Qiu
Journal:  World J Gastroenterol       Date:  2007-11-14       Impact factor: 5.742

2.  The association between clinical symptoms, laboratory findings and serum endothelin 1 concentrations, in cirrhotic patients with and without hepatopulmonary syndrome.

Authors:  Manouchehr Khoshbaten; Mohammad Rostami Nejad; Khalil Ansarin; Reza Fatemi; David Al Dulaimi; Faramarz Derakhshan; Nagmeh Jafarinia; Sophie Barford; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2012

3.  Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-β1/Smads and PI3K/Akt pathways.

Authors:  Liwei Wu; Qinghui Zhang; Wenhui Mo; Jiao Feng; Sainan Li; Jingjing Li; Tong Liu; Shizan Xu; Wenwen Wang; Xiya Lu; Qiang Yu; Kan Chen; Yujing Xia; Jie Lu; Ling Xu; Yingqun Zhou; Xiaoming Fan; Chuanyong Guo
Journal:  Sci Rep       Date:  2017-08-24       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.